PDHB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.829000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.740000E-01
Normal-vs-Stage2
2.324600E-01
Normal-vs-Stage3
3.401800E-01
Normal-vs-Stage4
5.700000E-01
Stage1-vs-Stage2
3.733200E-01
Stage1-vs-Stage3
4.018400E-01
Stage1-vs-Stage4
9.971600E-01
Stage2-vs-Stage3
4.357000E-01
Stage2-vs-Stage4
4.565200E-01
Stage3-vs-Stage4
4.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.005600E-01
Normal-vs-AfricanAmerican
2.803800E-01
Normal-vs-Asian
2.183600E-01
Caucasian-vs-AfricanAmerican
8.264200E-01
Caucasian-vs-Asian
5.806000E-01
AfricanAmerican-vs-Asian
8.668200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.386200E-01
Normal-vs-Female
3.608600E-01
Male-vs-Female
1.889430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.934200E-02
Normal-vs-Age(41-60Yrs)
2.532400E-01
Normal-vs-Age(61-80Yrs)
3.246200E-01
Normal-vs-Age(81-100Yrs)
2.698200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.597400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.292000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.871800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.217800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.994000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.661000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.398300E-02
Normal-vs-Daily Drinker
1.527760E-01
Normal-vs-Weekly Drinker
2.139200E-01
Normal-vs-Occasional Drinker
6.959000E-01
Normal-vs-Social Drinker
5.217400E-01
Non Drinker-vs-Daily Drinker
5.265400E-01
Non Drinker-vs-Weekly Drinker
2.916200E-01
Non Drinker-vs-Occasional Drinker
8.832500E-02
Non Drinker-vs-Social Drinker
1.183200E-01
Daily Drinker-vs-Weekly Drinker
6.461600E-01
Daily Drinker-vs-Occasional Drinker
1.905390E-01
Daily Drinker-vs-Social Drinker
3.278200E-01
Weekly Drinker-vs-Occasional Drinker
4.158800E-01
Weekly Drinker-vs-Social Drinker
6.013600E-01
Occasional Drinker-vs-Social Drinker
7.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.710600E-01
Normal-vs-Grade 2
5.871400E-01
Normal-vs-Grade 3
6.366000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.196800E-01
Grade 1-vs-Grade 3
7.386400E-01
Grade 1-vs-Grade 4
2.710600E-01
Grade 2-vs-Grade 3
2.521400E-01
Grade 2-vs-Grade 4
5.871400E-01
Grade 3-vs-Grade 4
6.366000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.559800E-01
Normal-vs-NonDiabetic
2.526600E-01
Diabetic-vs-NonDiabetic
6.360800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.702000E-01
Normal-vs-NoPancreatitis
2.634200E-01
Pancreatitis-vs-NoPancreatitis
8.477600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.858400E-01
Normal-vs-N1
2.142600E-01
N0-vs-N1
3.857000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.846200E-01
Normal-vs-TP53-NonMutant
4.614000E-01
TP53-Mutant-vs-TP53-NonMutant
7.677600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
